furosemide has been researched along with acetylcysteine in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.85) | 18.7374 |
1990's | 1 (3.85) | 18.2507 |
2000's | 8 (30.77) | 29.6817 |
2010's | 14 (53.85) | 24.3611 |
2020's | 2 (7.69) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Benek, O; Benkova, M; Dolezal, R; Hepnarova, V; Hrabinova, M; Janockova, J; Jun, D; Kobrlova, T; Korabecny, J; Kucera, T; Mezeiova, E; Prchal, L; Sobolova, K; Soukup, O | 1 |
Massey, TE; McElligott, TF; Racz, WJ; Walker, RM | 1 |
Beltrame, JF; Brennan, RJ; Horowitz, JD; Hunt, A; Moran, JL; Unger, SA; Zeitz, CJ | 1 |
Lepor, NE | 1 |
Airoldi, F; Briguori, C; Colombo, A; Morici, N | 1 |
Bernstein, SJ; Carlos, RC; Cronin, P; Dwamena, B; Kelly, AM | 1 |
Grainge, C; Rice, P | 1 |
Masubuchi, Y; Nakayama, J; Sadakata, Y | 1 |
Briguori, C; Condorelli, G; Ricciardelli, B; Visconti, G | 1 |
Airoldi, F; Briguori, C; Condorelli, G; Focaccio, A; Golia, B; Ricciardelli, B; Sangiorgi, GM; Valgimigli, M; Visconti, G | 1 |
Jazrawi, A; Khambatta, S; McCullough, PA | 1 |
De Capadocia Rosell, J; Jiménez Vizuete, JM; Lozano Serrano, B; Mateo Cerdá, CM | 1 |
Briguori, C; Condorelli, G; Donnarumma, E; Fiore, D; Quintavalle, C | 1 |
Franklin, T; Li, LP; Lu, J; Papadopoulou, MV; Prasad, PV; Solomon, R; Thacker, J; Zhou, Y | 1 |
Abramowitz, Y; Arbel, Y; Banai, S; Ben-Assa, E; Finkelstein, A; Halkin, A; Havakuk, O; Keren, G; Konigstein, M; Leshem-Rubinow, E; Schwartz, AL; Steinvil, A | 1 |
Bermúdez-Muñoz, JM; García-Alcántara, F; Martínez-Vega, R; Milo, M; Murillo-Cuesta, S; Pulido, S; Rivera, T; Varela-Nieto, I | 1 |
Szymański, M; Zadrożniak, M; Łuszczki, JJ | 1 |
Berglund, T; Greger, M; Landberg, T; Ohlsson, AB | 1 |
7 review(s) available for furosemide and acetylcysteine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A review of pharmacologic interventions to prevent contrast-induced nephropathy.
Topics: Acetylcysteine; Adenosine; Calcium Channel Blockers; Contrast Media; Creatinine; Fenoldopam; Furosemide; Hemodynamics; Humans; Kidney Diseases; Mannitol; Prostaglandins | 2003 |
New pharmacological protocols to prevent or reduce contrast media nephropathy.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Contrast Media; Diuretics; Fluid Therapy; Furosemide; Humans; Incidence; Kidney; Mannitol; Renal Insufficiency; Vasoconstriction; Vasodilator Agents | 2005 |
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Ascorbic Acid; Bicarbonates; Clinical Trials as Topic; Contrast Media; Furosemide; Protective Agents; Research Design; Theophylline | 2008 |
Management of phosgene-induced acute lung injury.
Topics: Acetylcysteine; Acute Lung Injury; Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cyclic AMP; Furosemide; Humans; Oxygen; Phosgene | 2010 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast Media; Creatinine; Diuretics; Drug Therapy, Combination; Equipment Design; Fluid Therapy; Furosemide; Glomerular Filtration Rate; Humans; Italy; Kidney Diseases; Radiography, Interventional; Renal Insufficiency; Research Design; Risk Assessment; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2011 |
Therapeutic strategies to prevent contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Calcium Channel Blockers; Contrast Media; Diuretics; Dopamine; Fenoldopam; Fluid Therapy; Furosemide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Treatment Outcome; Vasodilator Agents | 2013 |
4 trial(s) available for furosemide and acetylcysteine
Article | Year |
---|---|
Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema.
Topics: Acetylcysteine; Acute Disease; Diuretics; Drug Tolerance; Female; Free Radical Scavengers; Furosemide; Humans; Male; Morphine; Nitroglycerin; Prospective Studies; Pulmonary Edema; Treatment Outcome | 1998 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast Media; Creatinine; Diuretics; Drug Therapy, Combination; Equipment Design; Fluid Therapy; Furosemide; Glomerular Filtration Rate; Humans; Italy; Kidney Diseases; Radiography, Interventional; Renal Insufficiency; Research Design; Risk Assessment; Risk Factors; Sodium Bicarbonate; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2011 |
Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Carbonates; Contrast Media; Female; Fluid Therapy; Furosemide; Humans; Male; Renal Insufficiency; Risk Factors; Sodium Chloride | 2011 |
Forced diuresis with matched hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Cardiac Catheterization; Clinical Protocols; Contrast Media; Coronary Angiography; Diuresis; Diuretics; Double-Blind Method; Drug Administration Schedule; Fluid Therapy; Furosemide; Heart Valve Prosthesis Implantation; Humans; Infusions, Intravenous; Israel; Research Design; Sodium Chloride; Time Factors; Treatment Outcome; Urinary Catheterization | 2014 |
16 other study(ies) available for furosemide and acetylcysteine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile.
Topics: Berberine; Blood-Brain Barrier; Cell Line, Tumor; Cholinesterase Inhibitors; Cholinesterases; Drug Design; Humans; Prolyl Oligopeptidases | 2020 |
Furosemide toxicity in isolated mouse hepatocyte suspensions.
Topics: Acetylcysteine; Animals; Cell Membrane; Cell Membrane Permeability; Cell Survival; Cytoplasm; Furosemide; In Vitro Techniques; Liver; Male; Mice; Mice, Inbred Strains; Microvilli; Rats; Sulfhydryl Compounds | 1987 |
Protective effects of exogenous glutathione and related thiol compounds against drug-induced liver injury.
Topics: Acetaminophen; Acetylcysteine; Animals; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Female; Furosemide; Glutathione; Interleukin-6; Liver; Male; Mice; Mice, Inbred Strains | 2011 |
Minimizing the renal toxicity of iodinated contrast.
Topics: Acetylcysteine; Acute Kidney Injury; Carbonates; Contrast Media; Coronary Angiography; Female; Furosemide; Humans; Male; Sodium Chloride | 2011 |
[Presentation of a case of Paraquat poisoning].
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Ascorbic Acid; Charcoal; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Diuretics; Fatal Outcome; Furosemide; Gastric Lavage; Hemoperfusion; Humans; Immunosuppressive Agents; Male; Paraquat; Poisoning; Pulmonary Fibrosis; Respiration, Artificial; Respiratory Insufficiency; Rhabdomyolysis; Suicide, Attempted; Vitamin E | 2012 |
Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker.
Topics: Acetylcysteine; Acute Kidney Injury; Acute-Phase Proteins; Animals; Biomarkers; Contrast Media; Disease Models, Animal; Diuretics; Free Radical Scavengers; Furosemide; Iohexol; Ioxaglic Acid; Kidney; Lipocalin-2; Lipocalins; Magnetic Resonance Imaging; Male; Oxygen; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Triiodobenzoic Acids | 2014 |
The expression of oxidative stress response genes is modulated by a combination of resveratrol and N-acetylcysteine to ameliorate ototoxicity in the rat cochlea.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Auditory Fatigue; Brain Stem; Cochlea; Cytoprotection; Disease Models, Animal; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Furosemide; Gene Expression Regulation; Hearing; Hearing Loss; Inflammation Mediators; Kanamycin; Male; Oxidative Stress; Rats, Wistar; Reaction Time; Resveratrol | 2018 |
N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease.
Topics: Acetylcysteine; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Auditory Threshold; Deafness; Furosemide; Hearing; Hearing Loss; Mice; Ototoxicity | 2023 |
Increased metal tolerance in Salix by nicotinamide and nicotinic acid.
Topics: Acetylcysteine; Adaptation, Physiological; Analysis of Variance; Buthionine Sulfoximine; Cadmium; Chromatography, High Pressure Liquid; Copper; Enzyme Inhibitors; Glutathione; Metals; Niacin; Niacinamide; Pyrrolidonecarboxylic Acid; Salix; Thiazolidines; Zinc | 2008 |